José Antonio Arranz Amo

Institutions of which they are part

Postdoctoral researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)

Vall Hebron Institut de Recerca

José Antonio Arranz Amo

Institutions of which they are part

Postdoctoral researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)

Vall Hebron Institut de Recerca

Projects

Identificación y caracterización molecular de factores modificadores de la necrosis o de la regeneración muscular en el ratón mdx.

IP: -
Collaborators: José Antonio Arranz Amo, María Angeles Artaza Marino, Mireia del Toro Riera, Mario Marotta Baleriola
Funding agency: Instituto de Salud Carlos III
Funding: 91425
Reference: PI030106
Duration: 01/01/2003 - 28/11/2006

Related news

We develop a method to diagnose fatty liver in a quantitative and non-invasive way

Using computed tomography (CT), with or without contrast, it is possible to perform an accurate and safe detection of the disease without the need for biopsies and avoiding the limitations of other non-invasive diagnostic tools.

We study fatty liver and cardiovascular complications with digital twins

The European project, in which Vall d'Hebron participates, will favor personalized diagnosis and innovative therapeutic strategies in patients with the disease.